share_log

Form 144 | Collegium Pharmaceutical(COLL.US)关联方拟出售5.41万股股份,价值约178.85万美元

Form 144 | Collegium Pharmaceutical(COLL.US) Insider Proposes to Sell 1.79 Million in Common Stocks

Futu News ·  May 31 01:14

SEC FILLINGS DISCLOSED/ May 30, $Collegium Pharmaceutical (COLL.US)$ Insider Ciaffoni Joseph intends to sell 54,147 shares of its common stock on May 30, with a total market value of approximately $1.79 million.

Ciaffoni Joseph has reduced shareholding in $Collegium Pharmaceutical (COLL.US)$ by 103.14K shares since May 28, 2024, with a total value of approximately $3.48 million.

1717089267571717579.png

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment